COVID-19와 장기 후유증
COVID-19 and Long-Term Sequelae
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
After acute corona virus disease 2019 (COVID-19), there have been increasing reports of persistent and long-term symptoms similar to the post- viral syndromes described in survivors of severe acute respiratory syndrome (SARS) or middle east respiratory syndrome (MERS). Here, we provide a comprehensive review of the current literature on long-term COVID-19 focusing on organ- specific sequelae. Many of the recovered COVID-19 patients may be affected by long-term health. The future for COVID-19 survivors remains uncertain, and well conducted long term research will be needed.
Abstract
After acute corona virus disease 2019 (COVID-19), there have been increasing reports of persistent and long-term symptoms similar to the post- viral syndromes described in survivors of severe acute respiratory syndrome (SARS) or middle east respiratory syndrome (MERS). Here, we provide a comprehensive review of the current literature on long-term COVID-19 focusing on organ- specific sequelae. Many of the recovered COVID-19 patients may be affected by long-term health. The future for COVID-19 survivors remains uncertain, and well conducted long term research will be needed.
참고문헌 (30)
- Moldofsky H, "Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study", BMC Neurol, 11, pp.37~ (2011)
- Honigsbaum M, "Taking pandemic sequelae seriously : from the Russian influenza to COVID-19 long-haulers", Lancet, 396, pp.1389~1391 (2020)
- Lam MH, "Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors : long-term follow-up", Arch Intern Med, 169, pp.2142~2147 (2009)
- GroffD, "Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection : a systematic review", JAMA Netw Open, 4, pp.e2128568~ (2021)
- Gupta A, "Extrapulmonary manifestations of COVID-19", Nat Med, 26, pp.1017~1032 (2020)
- Pan XW, "Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak : a study based on single-cell transcriptome analysis", Intensive Care Med, 46, pp.1114~1116 (2020)
- Jin Y, "Endothelial activation and dysfunction in COVID-19 : from basic mechanisms to potential therapeutic approaches", Signal Transduct Target Ther, 5, pp.293~ (2020)
- Zhao YM, "Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery", EClinicalMedicine, 25, pp.100463~ (2020)
- Ehrenfeld M, "COVID-19 and autoimmunity", Autoimmun Rev, 19, pp.102597~ (2020)
- Mandal S, "'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19", Thorax, 76, pp.396~398 (2021)
- Huang C, "6-month consequences of COVID-19 in patients discharged from hospital : a cohort study", Lancet, 397, pp.220~232 (2021)
- George PM, "Respiratory follow-up of patients with COVID-19 pneumonia", Thorax, 75, pp.1009~1016 (2020)
- Bharat A, "Lung transplantation for patients with severe COVID-19", Sci Transl Med, 12, pp.eabe4282~ (2020)
- Myall KJ, "Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment", Ann Am Thorac Soc, 18, pp.799~806 (2021)
- Patell R, "Postdischarge thrombosis and hemorrhage in patients with COVID-19", Blood, 136, pp.1342~1346 (2020)
- Bikdeli B, "COVID-19 and thrombotic or thromboembolic disease : implications for prevention, antithrombotic therapy, and follow-up : JACC state-of-the-art review", J Am Coll Cardiol, 75, pp.2950~2973 (2020)
- Carfì A, "Persistent symptoms in patients after acute COVID-19", JAMA, 324, pp.603~605 (2020)
- Jabri A, "Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic", JAMA Netw Open, 3, pp.e2014780~ (2020)
- Wu Q, "Altered lipid metabolism in recovered SARS patients twelve years after infection", Sci Rep, 7, pp.9110~ (2017)
- Desai AD, "Management of arrhythmias associated with COVID-19", Curr Cardiol Rep, 23, pp.2~ (2020)
- Joseph V. Pergolizzi, "Potential neurological manifestations of COVID-19: a narrative review", Postgraduate Medicine, 134(4), pp.395~405 (2021), Informa UK Limited[DOI]
- Mazza MG, "Anxiety and depression in COVID-19 survivors : role of inflammatory and clinical predictors", Brain Behav Immun, 89, pp.594~600 (2020)
- Taquet M, "Bidirectional associations between COVID-19 and psychiatric disorder : retrospective cohort studies of 62 354 COVID-19 cases in the USA", Lancet Psychiatry, 8, pp.130~140 (2021)
- Mateu-Salat M, "SARS-COV-2 as a trigger for autoimmune disease : report of two cases of Graves' disease after COVID-19", J Endocrinol Invest, 43, pp.1527~1528 (2020)
- Suwanwongse K, "Newly diagnosed diabetes mellitus, DKA, and COVID-19: causality or coincidence? A report of three cases", J Med Virol, 93, pp.1150~1153 (2021)
- Stevens JS, "High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy", PLoS One, 15, pp.e0244131~ (2020)
- Cummings MJ, "Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City : a prospective cohort study", Lancet, 395, pp.1763~1770 (2020)
- Velez JCQ, "COVAN is the new HIVAN : the re-emergence of collapsing glomerulopathy with COVID-19", Nat Rev Nephrol, 16, pp.565~567 (2020)
- Zuo T, "Alterations in gut microbiota of patients with COVID-19 during time of hospitalization", Gastroenterology, 159, pp.944~955.e8 (2020)
- Mirza FN, "Dermatologic manifestations of COVID-19 : a comprehensive systematic review", Int J Dermatol, 60, pp.418~450 (2021)
